{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:15:52Z","timestamp":1788909352109,"version":"build-2803163510"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T00:00:00Z","timestamp":1659916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The global emergence and spread of extended-spectrum beta-lactamase (ESBL)-producing\n                      <jats:italic>Enterobacterales<\/jats:italic>\n                      , especially\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      and\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      , have been recognized as a public health concern as severe infections caused by these microorganisms increase morbidity and mortality. This study aimed to assess the prevalence of ESBL-positive\n                      <jats:italic>E. coli<\/jats:italic>\n                      and\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      strains isolated from hospitalized patients in Chiangrai Prachanukroh hospital, Chiangrai province, Thailand.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective analysis was conducted from January 2016 to December 2020.\u00a0A total of 384,001 clinical specimens were collected aseptically and further cultivated on an appropriate medium. All clinical isolates (one isolate per patient) were identified based on standard laboratory methods. Antibiotic susceptibility testing was performed by the Kirby Bauer disc diffusion technique following CLSI guidelines. ESBL production was screened with ceftazidime and cefotaxime discs based on the CLSI recommendations. Phenotypic confirmation of ESBL production was carried out using a double-disc synergy technique following the CLSI standard.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of a total of 384,001 clinical samples analyzed for bacterial species identification, 11,065 (2.9%) tested positive for\n                      <jats:italic>E. coli<\/jats:italic>\n                      and 5,617 (1.5%) for\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      . Approximately 42.5% (4,706\/11,065) of\n                      <jats:italic>E. coli<\/jats:italic>\n                      and 30.2% (1,697\/5,617) of\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      isolates were classified as ESBL producers. A higher proportion of ESBL producers was found in patients older than 60 years and male groups. The highest infection rates of ESBL-positive pathogens were observed among patients in a medical unit. ESBL-producing\n                      <jats:italic>E. coli<\/jats:italic>\n                      and\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      isolates were predominantly found in urine and sputum, respectively. ESBL producers exhibited a high resistance rate to ampicillin (99.8\u2013100%), cefazolin (100%), cefotaxime (100%), fluoroquinolones, and trimethoprim\/sulfamethoxazole.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This study demonstrated the high prevalence and emerging antibiotic resistance of ESBL-positive\n                      <jats:italic>E. coli<\/jats:italic>\n                      and\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      isolates from patients admitted to a provincial hospital in northern Thailand. Most ESBL-producing strains were highly resistant to several antimicrobial agents apart from carbapenems and aminoglycosides. These findings indicated that carbapenems and aminoglycosides should be advised as the first-line drugs of choice for serious infections with ESBL-producing\n                      <jats:italic>Enterobacterales<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2022.955774","type":"journal-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T02:25:57Z","timestamp":1659925557000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["High prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates: A 5-year retrospective study at a Tertiary Hospital in Northern Thailand"],"prefix":"10.3389","volume":"12","author":[{"given":"Achiraya","family":"Siriphap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thawatchai","family":"Kitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akachai","family":"Khuekankaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chalermchai","family":"Boonlao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chonthida","family":"Thephinlap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chutamas","family":"Thepmalee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nittiya","family":"Suwannasom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krissana","family":"Khoothiam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4846159","article-title":"Isolation of extended-spectrum \u03b2-lactamase- (ESBL-) producing Escherichia coli and Klebsiella pneumoniae from patients with community-onset urinary tract infections in jimma university specialized hospital, southwest Ethiopia","volume":"2018","author":"Abayneh","year":"2018","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1086\/518725","article-title":"Risk factors for and outcomes of healthcare-associated infection due to extended-spectrum beta-Lactamase-Producing Escherichia coli or Klebsiella pneumoniae in Thailand","volume":"28","author":"Apisarnthanarak","year":"2007","journal-title":"Infect. Control Hosp Epidemiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-4-45","article-title":"Surveillance of antimicrobial resistance at a tertiary hospital in Tanzania","volume":"4","author":"Blomberg","year":"2004","journal-title":"BMC Public Health"},{"key":"B4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1146\/annurev-micro-090110-102911","article-title":"Epidemiological expansion, structural studies, and clinical challenges of new \u03b2-lactamases from gram-negative bacteria","volume":"65","author":"Bush","year":"2011","journal-title":"Annu. Rev. Microbiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ijid.2017.10.025","article-title":"Beta-lactam resistance among enterobacteriaceae in Cambodia: The four-year itch","volume":"66","author":"Caron","year":"2018","journal-title":"Int. J. Infect. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1186\/1756-0500-6-487","article-title":"Prevalence of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae urinary isolates in a tertiary care hospital in Kathmandu, Nepal","volume":"6","author":"Chander","year":"2013","journal-title":"BMC. Res. Notes"},{"key":"B7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jmii.2014.05.003","article-title":"Bacteremic pneumonia caused by extended-spectrum beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Appropriateness of empirical treatment matters","volume":"49","author":"Cheng","year":"2016","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B8","volume-title":"Performance standard for antimicrobial susceptibility testing: Twenty-fourth informational supplement M100-S24","year":"2014"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1128\/jcm.35.10.2593-2597.199","article-title":"Occurrence and detection of extended-spectrum beta-lactamases in members of the family enterobacteriaceae at a veterans medical center: Seek and you may find","volume":"35","author":"Coudron","year":"1997","journal-title":"J. Clin. Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"645","DOI":"10.7860\/JCDR\/2012\/.2117","article-title":"Antibiotic resistance patterns in uropathogens at a tertiary care hospital at jhalawar with special referenceAmpC b-lactamase and MRSA production","volume":"6","author":"Dalela","year":"2012","journal-title":"J. Clin. Diag.n Res."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189621","article-title":"Clinical and economic impact of antibiotic resistance in developing countries: ASystematic review and meta-analysis","volume":"12","author":"Founou","year":"2017","journal-title":"PloS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1038\/s41598-020-59772-z","article-title":"Molecular characterization of extended-spectrum \u03b2 lactamase- producing E. coli recovered from community-acquired urinary tract infections in upper Egypt","volume":"10","author":"Hassuna","year":"2020","journal-title":"Sci. Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10096-016-2776-8","article-title":"Uropathogen distribution and antimicrobial susceptibility in uncomplicated cystitis in Belgium, a high antibiotics prescribing country: 20-year surveillance","volume":"36","author":"Heytens","year":"2017","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109324","article-title":"Increasing incidence of hospital-acquired and healthcare-associated bacteremia in northeast Thailand: AMulticenter surveillance study","volume":"9","author":"Hongsuwan","year":"2014","journal-title":"PloS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1128\/JCM.00062-06","article-title":"Identification of extended-spectrum, AmpC, and carbapenem- hydrolyzing beta-lactamases in Escherichia coli and Klebsiella pneumoniae by disk tests","volume":"44","author":"Jacoby","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.663033","article-title":"High prevalence of extended-spectrum beta-lactamases in Escherichia coli strains collected from strictly defined community-acquired urinary tract infections in adults in China: A multicenter prospective clinical microbiological and molecular study","volume":"12","author":"Jia","year":"2021","journal-title":"Front. Microbiol."},{"key":"B17","doi-asserted-by":"crossref","DOI":"10.1128\/9781555817381","volume-title":"Manual of clinical microbiology. eleventh edition","author":"Jorgensen","year":"2015"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.720701","article-title":"Antibiotic resistance pattern of extended spectrum beta lactamase producing Escherichia coli isolated from patients with urinary tract infection in Morocco","volume":"11","author":"Kettani Halabi","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3855\/jidc.127","article-title":"Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: Trends in the hospital and community settings","volume":"3","author":"Khanfar","year":"2009","journal-title":"J. Infect. Dev. Ctries"},{"key":"B20","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.4314\/ahs.v11i3.70069","article-title":"Antimicrobial susceptibility patterns of E. coli from clinical sources in northeast Ethiopia","author":"Kibret","year":"2011","journal-title":"Afr Health Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1128\/aac.46.5.1481-1491.2002","article-title":"Bloodstream infections by extended-spectrum beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in children: Epidemiology and clinical outcome","volume":"46","author":"Kim","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1128\/aac.00171-08","article-title":"Molecular characterization and epidemiology of extended-Spectrum-Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-m family is endemic","volume":"52","author":"Kiratisin","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1086\/322667","article-title":"Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae","volume":"33","author":"Lautenbach","year":"2001","journal-title":"Clin. Infec.t Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1093\/cid\/cis1043","article-title":"Public health risks of enterobacterial isolates producing extended-spectrum \u03b2-lactamases or AmpC \u03b2-lactamases in food and food-producing animals: An EU perspective of epidemiology, analytical methods, risk factors, and control options","volume":"56","author":"Liebana","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.30476\/IJMS.2010.39762","article-title":"Prevalence of multiple drug resistant clinical isolates of extended-spectrum beta-lactamase producing enterobacteriaceae in southeast Iran","volume":"35","author":"Mansouri","year":"2010","journal-title":"Iran J. Med. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"E580","DOI":"10.9778\/cmajo.20180039","article-title":"Emerging antimicrobial resistance among Escherichia coli strains in bloodstream infections in toront-2016: A retrospective cohort study","volume":"6","author":"Mineau","year":"2018","journal-title":"CMAJ Open"},{"key":"B27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/mop.0000000000000182","article-title":"The contribution of extended-spectrum \u03b2-lactamases to multidrug-resistant infections in children","volume":"27","author":"Murray","year":"2015","journal-title":"Curr. Opin. Pediatr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13104-016-2049-8","article-title":"Antimicrobial susceptibility profiles of Escherichia coli and Klebsiella pneumoniae isolated from outpatients in urban and rural districts of Uganda","volume":"9","author":"Najjuka","year":"2016","journal-title":"BMC Res. Notes"},{"key":"B29","doi-asserted-by":"publisher","first-page":"960","DOI":"10.4269\/ajtmh.12-0642","article-title":"High levels of extended-spectrum beta-lactamases in a major teaching hospital in Ghana: the need for regular monitoring and evaluation of antibiotic resistance","volume":"89","author":"Obeng-Nkrumah","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B30","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s12879-016-1655-3","article-title":"High prevalence of extended-spectrum \u00df-lactamase producing enterobacteriaceae among clinical isolates in Burkina Faso","volume":"16","author":"Ouedraogo","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.amjmed.2006.03.013","article-title":"Resistance in gram-negative bacteria: Enterobacteriaceae","volume":"119","author":"Paterson","year":"2006","journal-title":"Am. J. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/cmr.18.4.657-686.2005","article-title":"Extended-spectrum beta-lactamases: A clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.5812\/archcid.32696","article-title":"High frequency of extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates from male patients\u2019 Urine","volume":"11","author":"Peerayeh","year":"2016","journal-title":"Arch. Clin. Infect. Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/s1473-3099(08)70041-0","article-title":"Extended-spectrum beta-Lactamase-Producing enterobacteriaceae: an emerging public-health concern","volume":"8","author":"Pitout","year":"2008","journal-title":"Lancet Infect. Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/j.1469-0691.2011.03737.x","article-title":"Evaluation of a diagnostic flow chart for detection and confirmation of extended spectrum b-lactamases (ESBL) in Enterobacteriaceae","volume":"18","author":"Polsfuss","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"B36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/jac\/dkw372","article-title":"High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China","volume":"72","author":"Quan","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4103\/0974-777x.68531","article-title":"Extended-spectrum \u03b2-lactamases in gram negative bacteria","volume":"2","author":"Rawat","year":"2010","journal-title":"J. Glob. Infect. Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"943","DOI":"10.4269\/ajtmh.18-0394","article-title":"High burden of extended-spectrum \u03b2-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae bacteremia in older adults: A seven-year study in two rural Thai provinces","volume":"100","author":"Sawatwong","year":"2019","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B39","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1093\/jac\/dkm318","article-title":"Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in enterobacteriaceae bacteraemia: A systematic review and meta-analysis","volume":"60","author":"Schwaber","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"B40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12873-016-0106-1","article-title":"Comparison of antimicrobial resistance patterns of ESBL and non ESBL bacterial isolates among patients with secondary peritonitis at Bugando medical centre, Mwanza \u2013 Tanzania","volume":"16","author":"Seni","year":"2016","journal-title":"BMC. Emerg. Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-016-0115-6","article-title":"Epidemiology and molecular characterization of multidrug-resistant gram-negative bacteria in southeast Asia","volume":"5","author":"Suwantarat","year":"2016","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"B42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13756-019-0488-4","article-title":"Extended-spectrum beta-lactamase production and multi-drug resistance among enterobacteriaceae isolated in Addis Ababa, Ethiopia","volume":"8","author":"Teklu","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"B43","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jgar.2018.12.014","article-title":"A retrospective analysis of risk factors and outcomes in patients with extended-spectrum beta-Lactamase-Producing Escherichia coli bloodstream infections","volume":"17","author":"Xiao","year":"2019","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"B44","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ijantimicag.2014.11.012","article-title":"In vitro activity of flomoxef and aomparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum \u03b2-lactamases in China","volume":"45","author":"Yang","year":"2015","journal-title":"Int. J. Antimicrob. Agents"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.955774\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T02:26:00Z","timestamp":1659925560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.955774\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,8]]},"references-count":44,"alternative-id":["10.3389\/fcimb.2022.955774"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.955774","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,8]]},"article-number":"955774"}}